Concept of treatment and adjustment of DNA molecule.
Natali_Mis/Shutterstock
Category Icon

Emerging

Article Abstracts
Feb 28, 2025
Emerging icon

Emerging

In Vivo Gene Editing

Article Abstracts
Nov 12, 2026

Several companies are experimenting on human subjects to develop gene editing that is performed inside the body. Such therapies differ from a recently approved treatment for sickle-cell anemia that removes bone marrow from the body before editing the genetic material and reintroducing it into the patient.

Intellia Therapeutics and Regeneron Pharmaceuticals are in clinical trials to use gene editing to knock out a gene that causes fibrous protein clumps, which can accumulate in organs and nerves, increasing the risk of heart failure and other serious complications. Verve Therapeutics is enrolling patients to test a gene-editing protocol designed to reverse the effects of a genetic disease that leads to severely elevated cholesterol and increased risk of early-onset cardiovascular disease.

One caveat: These therapies carry the risk of editing unrelated genes.

 

 
REFERENCES
Advanced Search on this topic

Other Articles in this category

Jul 28, 2026 | Emerging
The use of glucagon like peptide-1 (GLP-1) weight-loss drugs to control obesity and Type-2 diabetes is on the rise. J.P. Morgan Global Research …
May 29, 2026 | Emerging
Imagine a technology so powerful it can bypass the muscles and connect directly to a user's thoughts. Today, medical science is turning this science…
May 20, 2026 | Emerging
In a 2026 study published in Geriatrics (Basel), researchers explored how a 12-week yoga program could help older adults (ages 65–85) stay steady and…
Apr 22, 2026 | Emerging
On February 12, 2026, the United States Environmental Protection Agency (EPA) finalized a rule rescinding its 2009 Endangerment Finding, which had…